{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:43:36Z","timestamp":1791333816718,"version":"4.3.1"},"reference-count":269,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s40263-024-01082-3","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T18:01:39Z","timestamp":1712340099000},"page":"349-373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["CNS Viral Infections\u2014What to Consider for Improving Drug Treatment: A Plea for Using Mathematical Modeling Approaches"],"prefix":"10.1007","volume":"38","author":[{"given":"Ming","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn L.","family":"Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8303-1117","authenticated-orcid":false,"given":"Elizabeth C. M.","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"key":"1082_CR1","doi-asserted-by":"crossref","first-page":"117957351770334","DOI":"10.1177\/1179573517703342","volume":"9","author":"PB Bookstaver","year":"2017","unstructured":"Bookstaver PB, Mohorn PL, Shah A, et al. Management of viral central nervous system infections: a primer for clinicians. J Central Nerv Syst Dis. 2017;9:1179573517703342.","journal-title":"J Central Nerv Syst Dis."},{"issue":"6","key":"1082_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1055\/s-0035-1564686","volume":"35","author":"MB Richie","year":"2015","unstructured":"Richie MB, Josephson SA. A practical approach to meningitis and encephalitis. Semin Neurol. 2015;35(6):611\u201320.","journal-title":"Semin Neurol"},{"key":"1082_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coviro.2014.12.009","volume":"11","author":"PA Swanson","year":"2015","unstructured":"Swanson PA, McGavern DB. Viral diseases of the central nervous system. Curr Opin Virol. 2015;11:44\u201354.","journal-title":"Curr Opin Virol"},{"key":"1082_CR4","volume-title":"Viral meningitis","author":"RM Cantu","year":"2022","unstructured":"Cantu RM, Das JM. Viral meningitis. Treasure Island: StatPearls Publishing LLC; 2022."},{"key":"1082_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijid.2018.06.008","volume":"73","author":"F Ben Abid","year":"2018","unstructured":"Ben Abid F, Abukhattab M, Ghazouani H, et al. Epidemiology and clinical outcomes of viral central nervous system infections. Int J Infect Dis. 2018;73:85\u201390.","journal-title":"Int J Infect Dis"},{"issue":"8405","key":"1082_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0140-6736(84)92623-0","volume":"2","author":"B Sk\u00f6ldenberg","year":"1984","unstructured":"Sk\u00f6ldenberg B, Forsgren M, Alestig K, et al. Acyclovir versus vidarabine in herpes simplex encephalitis: randomised multicentre study in consecutive Swedish patients. Lancet. 1984;2(8405):707\u201311.","journal-title":"Lancet"},{"issue":"6","key":"1082_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1056\/NEJM197708112970601","volume":"297","author":"RJ Whitley","year":"1977","unstructured":"Whitley RJ, Soong SJ, Dolin R, et al. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977;297(6):289\u201394.","journal-title":"N Engl J Med"},{"key":"1082_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/B978-0-12-800964-2.00003-3","volume-title":"Viral pathogenesis","author":"RW Doms","year":"2016","unstructured":"Doms RW. Basic concepts: a step-by-step guide to viral infection. In: Viral pathogenesis. Elsevier; 2016. p. 29\u201340."},{"issue":"4","key":"1082_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.chom.2013.03.010","volume":"13","author":"OO Koyuncu","year":"2013","unstructured":"Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host Microbe. 2013;13(4):379\u201393.","journal-title":"Cell Host Microbe"},{"issue":"3","key":"1082_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1086\/589747","volume":"47","author":"AR Tunkel","year":"2008","unstructured":"Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47(3):303\u201327.","journal-title":"Clin Infect Dis"},{"issue":"13","key":"1082_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199803263381301","volume":"338","author":"FJ Palella Jr","year":"1998","unstructured":"Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853\u201360.","journal-title":"N Engl J Med"},{"issue":"3","key":"1082_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1056\/NEJM198601163140303","volume":"314","author":"RJ Whitley","year":"1986","unstructured":"Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986;314(3):144\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"1082_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/00002030-200003310-00007","volume":"14","author":"BM Anduze-Faris","year":"2000","unstructured":"Anduze-Faris BM, Fillet AM, Gozlan J, et al. Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. AIDS. 2000;14(5):517\u201324.","journal-title":"AIDS"},{"issue":"Suppl. 2","key":"1082_CR14","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1093\/ofid\/ofz360.439","volume":"6","author":"R Cutler","year":"2019","unstructured":"Cutler R, Trentman S, Jandarov R, et al. Severe neurologic impairment persists despite potent ART in HIV encephalopathy. Open Forum Infect Dis. 2019;6(Suppl. 2):S192. https:\/\/doi.org\/10.1093\/ofid\/ofz360.439.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"1082_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-015-1511-3","volume":"131","author":"M Ludlow","year":"2016","unstructured":"Ludlow M, Kortekaas J, Herden C, et al. Neurotropic virus infections as the cause of immediate and delayed neuropathology. Acta Neuropathol. 2016;131(2):159\u201384.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1082_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1056\/NEJMra1708714","volume":"379","author":"KL Tyler","year":"2018","unstructured":"Tyler KL. Acute viral encephalitis. N Engl J Med. 2018;379(6):557\u201366.","journal-title":"N Engl J Med"},{"issue":"1","key":"1082_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/1389200043489126","volume":"5","author":"CL Graff","year":"2004","unstructured":"Graff CL, Pollack GM. Drug transport at the blood-brain barrier and the choroid plexus. Curr Drug Metab. 2004;5(1):95\u2013108.","journal-title":"Curr Drug Metab"},{"issue":"4","key":"1082_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1146\/annurev.pharmtox.41.1.569","volume":"53","author":"G Lee","year":"2001","unstructured":"Lee G, Dallas S, Hong M,\u00a0et al. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. Pharmacol Rev. 2001;53(4):569\u201396.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"1082_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0165-0173(91)90020-9","volume":"16","author":"A Minn","year":"1991","unstructured":"Minn A, Ghersi-Egea JF, Perrin R, et al. Drug metabolizing enzymes in the brain and cerebral microvessels. Brain Res Brain Rev. 1991;16(1):65\u201382.","journal-title":"Brain Res Brain Rev."},{"issue":"4","key":"1082_CR20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/138920007780655478","volume":"8","author":"RP Meyer","year":"2007","unstructured":"Meyer RP, Gehlhaus M, Knoth R, et al. Expression and function of cytochrome p450 in brain drug metabolism. Curr Drug Metab. 2007;8(4):297\u2013306.","journal-title":"Curr Drug Metab"},{"issue":"6","key":"1082_CR21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0149-7634(98)00009-8","volume":"22","author":"RS Tirabassi","year":"1998","unstructured":"Tirabassi RS, Townley RA, Eldridge MG, et al. Molecular mechanisms of neurotropic herpesvirus invasion and spread in the CNS. Neurosci Biobehav Rev. 1998;22(6):709\u201320.","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"1082_CR22","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1073\/pnas.0913351107","volume":"107","author":"T Suenaga","year":"2010","unstructured":"Suenaga T, Satoh T, Somboonthum P, et al. Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses. Proc Natl Acad Sci U S A. 2010;107(2):866\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1082_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-micro-092611-150051","volume":"66","author":"G Smith","year":"2012","unstructured":"Smith G. Herpesvirus transport to the nervous system and back again. Ann Rev Microbiol. 2012;66:153\u201376.","journal-title":"Ann Rev Microbiol."},{"issue":"22","key":"1082_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01227-21","volume":"95","author":"L Rajbhandari","year":"2021","unstructured":"Rajbhandari L, Shukla P, Jagdish B, et al. Nectin-1 is an entry mediator for varicella-zoster virus infection of human neurons. J Virol. 2021;95(22):e0122721.","journal-title":"J Virol"},{"issue":"11","key":"1082_CR25","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1097\/j.pain.0000000000002051","volume":"161","author":"S Shiers","year":"2020","unstructured":"Shiers S, Ray PR, Wangzhou A, et al. ACE2 and SCARF expression in human dorsal root ganglion nociceptors: implications for SARS-CoV-2 virus neurological effects. Pain. 2020;161(11):2494\u2013501.","journal-title":"Pain"},{"key":"1082_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.610964","volume":"13","author":"PM Rodr\u00edguez Cruz","year":"2020","unstructured":"Rodr\u00edguez Cruz PM, Cossins J, Beeson D, et al. The neuromuscular junction in health and disease: molecular mechanisms governing synaptic formation and homeostasis. Front Mol Neurosci. 2020;13:610964.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"1082_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1128\/jvi.66.1.296-304.1992","volume":"66","author":"R Ren","year":"1992","unstructured":"Ren R, Racaniello VR. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J Virol. 1992;66(1):296\u2013304.","journal-title":"J Virol"},{"key":"1082_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/B978-0-12-387040-7.00010-X","volume":"79","author":"G Ugolini","year":"2011","unstructured":"Ugolini G. Rabies virus as a transneuronal tracer of neuronal connections. Adv Virus Res. 2011;79:165\u2013202.","journal-title":"Adv Virus Res"},{"issue":"1","key":"1082_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/13550280590900427","volume":"11","author":"M Lafon","year":"2005","unstructured":"Lafon M. Rabies virus receptors. J Neurovirol. 2005;11(1):82\u20137.","journal-title":"J Neurovirol"},{"issue":"5","key":"1082_CR30","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/WCO.0000000000000970","volume":"34","author":"J Suh","year":"2021","unstructured":"Suh J, Amato AA. Neuromuscular complications of coronavirus disease-19. Curr Opin Neurol. 2021;34(5):669\u201374.","journal-title":"Curr Opin Neurol"},{"key":"1082_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev.neuro.29.051605.112950","volume":"29","author":"RI Wilson","year":"2006","unstructured":"Wilson RI, Mainen ZF. Early events in olfactory processing. Ann Rev Neurosci. 2006;29:163\u2013201.","journal-title":"Ann Rev Neurosci."},{"issue":"2","key":"1082_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/13550280590922793","volume":"11","author":"I Mori","year":"2005","unstructured":"Mori I, Nishiyama Y, Yokochi T, et al. Olfactory transmission of neurotropic viruses. J Neurovirol. 2005;11(2):129\u201337.","journal-title":"J Neurovirol"},{"issue":"11","key":"1082_CR33","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1021\/acschemneuro.0c00210","volume":"11","author":"K Bilinska","year":"2020","unstructured":"Bilinska K, Jakubowska P, Von Bartheld CS, et al. Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: identification of cell types and trends with age. ACS Chem Neurosci. 2020;11(11):1555\u201362.","journal-title":"ACS Chem Neurosci"},{"issue":"4","key":"1082_CR34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/cpt.75","volume":"97","author":"BP Daniels","year":"2015","unstructured":"Daniels BP, Klein RS. Viral sensing at the blood-brain barrier: new roles for innate immunity at the CNS vasculature. Clin Pharmacol Ther. 2015;97(4):372\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"1082_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020472","volume":"6","author":"D R\u016f\u017eek","year":"2011","unstructured":"R\u016f\u017eek D, Sal\u00e1t J, Singh SK, et al. Breakdown of the blood\u2013brain barrier during tick-borne encephalitis in mice is not dependent on CD8+ T cells. PLoS ONE. 2011;6(5):e20472.","journal-title":"PLoS ONE"},{"issue":"4","key":"1082_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.01675-19","volume":"10","author":"S Bonney","year":"2019","unstructured":"Bonney S, Seitz S, Ryan CA, et al. Gamma interferon alters junctional integrity via Rho kinase, resulting in blood-brain barrier leakage in experimental viral encephalitis. MBio. 2019;10(4):10\u20131128.","journal-title":"MBio"},{"issue":"18","key":"1082_CR37","doi-asserted-by":"publisher","first-page":"8978","DOI":"10.1128\/JVI.00314-08","volume":"82","author":"P Wang","year":"2008","unstructured":"Wang P, Dai J, Bai F, et al. Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J Virol. 2008;82(18):8978\u201385.","journal-title":"J Virol"},{"issue":"1","key":"1082_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12987-022-00372-6","volume":"19","author":"D Thompson","year":"2022","unstructured":"Thompson D, Brissette CA, Watt JA. The choroid plexus and its role in the pathogenesis of neurological infections. Fluids Barriers CNS. 2022;19(1):75.","journal-title":"Fluids Barriers CNS."},{"key":"1082_CR39","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/B978-0-12-802381-5.00020-8","volume-title":"Conn\u2019s translational neuroscience","author":"CE Johanson","year":"2017","unstructured":"Johanson CE. Chapter 11: Choroid plexus-cerebrospinal fluid transport dynamics: support of brain health and a role in neurotherapeutic. In: Conn PM, editor. Conn\u2019s translational neuroscience. Academic Press; 2017. p. 233\u201361."},{"key":"1082_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42399-020-00522-7","volume":"2","author":"S Jakhmola","year":"2020","unstructured":"Jakhmola S, Indari O, Chatterjee S, et al. SARS-CoV-2, an underestimated pathogen of the nervous system. SN Compr Clin Med. 2020;2:1\u201310.","journal-title":"SN Compr Clin Med."},{"issue":"2","key":"1082_CR41","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis MLC, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631\u20137.","journal-title":"J Pathol"},{"issue":"9","key":"1082_CR42","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1007\/s00415-021-10406-y","volume":"268","author":"BN Harapan","year":"2021","unstructured":"Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol. 2021;268(9):3059\u201371.","journal-title":"J Neurol"},{"issue":"2","key":"1082_CR43","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1750-3639.2007.00067.x","volume":"17","author":"S Man","year":"2007","unstructured":"Man S, Ubogu EE, Ransohoff RM. Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathol. 2007;17(2):243\u201350.","journal-title":"Brain Pathol"},{"issue":"12","key":"1082_CR44","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.it.2012.07.004","volume":"33","author":"B Engelhardt","year":"2012","unstructured":"Engelhardt B, Ransohoff RM. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 2012;33(12):579\u201389.","journal-title":"Trends Immunol"},{"issue":"1","key":"1082_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12987-020-00196-2","volume":"17","author":"P Sol\u00e1r","year":"2020","unstructured":"Sol\u00e1r P, Zamani A, Kub\u00ed\u010dkov\u00e1 L, et al. Choroid plexus and the blood-cerebrospinal fluid barrier in disease. Fluids Barriers CNS. 2020;17(1):35.","journal-title":"Fluids Barriers CNS."},{"issue":"5","key":"1082_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037886","volume":"7","author":"Z Xu","year":"2012","unstructured":"Xu Z, Waeckerlin R, Urbanowski MD, et al. West Nile virus infection causes endocytosis of a specific subset of tight junction membrane proteins. PLoS ONE. 2012;7(5):e37886.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"1082_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jneuroim.2010.08.003","volume":"230","author":"C Casiraghi","year":"2011","unstructured":"Casiraghi C, Dorovini-Zis K, Horwitz MS. Epstein-Barr virus infection of human brain microvessel endothelial cells: a novel role in multiple sclerosis. J Neuroimmunol. 2011;230(1\u20132):173\u20137.","journal-title":"J Neuroimmunol"},{"issue":"6831","key":"1082_CR48","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/35073667","volume":"410","author":"M Kaul","year":"2001","unstructured":"Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 2001;410(6831):988\u201394.","journal-title":"Nature"},{"key":"1082_CR49","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3389\/fneur.2020.00659","volume":"11","author":"J Huang","year":"2020","unstructured":"Huang J, Zheng M, Tang X, et al. Potential of SARS-CoV-2 to cause CNS infection: biologic fundamental and clinical experience. Front Neurol. 2020;11:659.","journal-title":"Front Neurol"},{"issue":"2","key":"1082_CR50","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1083\/jcb.84.2.404","volume":"84","author":"A Helenius","year":"1980","unstructured":"Helenius A, Kartenbeck J, Simons K, et al. On the entry of Semliki forest virus into BHK-21 cells. J Cell Biol. 1980;84(2):404\u201320.","journal-title":"J Cell Biol"},{"issue":"2","key":"1082_CR51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrmicro817","volume":"2","author":"DS Dimitrov","year":"2004","unstructured":"Dimitrov DS. Virus entry: molecular mechanisms and biomedical applications. Nat Rev Microbiol. 2004;2(2):109\u201322.","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"1082_CR52","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006866","volume":"2","author":"CB Wilen","year":"2012","unstructured":"Wilen CB, Tilton JC, Doms RW. HIV: cell binding and entry. Cold Spring Harbor Perspect Med. 2012;2(8):a006866.","journal-title":"Cold Spring Harbor Perspect Med."},{"issue":"5","key":"1082_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007660","volume":"15","author":"AT Hilterbrand","year":"2019","unstructured":"Hilterbrand AT, Heldwein EE. Go go gadget glycoprotein!: HSV-1 draws on its sizeable glycoprotein tool kit to customize its diverse entry routes. PLoS Pathog. 2019;15(5):e1007660.","journal-title":"PLoS Pathog"},{"issue":"3","key":"1082_CR54","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1083\/jcb.107.3.959","volume":"107","author":"CD Pauza","year":"1988","unstructured":"Pauza CD, Price TM. Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis. J Cell Biol. 1988;107(3):959\u201368.","journal-title":"J Cell Biol"},{"issue":"6","key":"1082_CR55","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1128\/JVI.75.6.2993-3000.2001","volume":"75","author":"E Schaeffer","year":"2001","unstructured":"Schaeffer E, Geleziunas R, Greene WC. Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions. J Virol. 2001;75(6):2993\u20133000.","journal-title":"J Virol"},{"issue":"5","key":"1082_CR56","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/0092-8674(87)90542-3","volume":"49","author":"BS Stein","year":"1987","unstructured":"Stein BS, Gowda SD, Lifson JD, et al. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell. 1987;49(5):659\u201368.","journal-title":"Cell"},{"issue":"12","key":"1082_CR57","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.tim.2010.09.003","volume":"18","author":"M Permanyer","year":"2010","unstructured":"Permanyer M, Ballana E, Est\u00e9 JA. Endocytosis of HIV: anything goes. Trends Microbiol. 2010;18(12):543\u201351.","journal-title":"Trends Microbiol"},{"issue":"3","key":"1082_CR58","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1128\/JVI.78.3.1375-1383.2004","volume":"78","author":"E Schaeffer","year":"2004","unstructured":"Schaeffer E, Soros VB, Greene WC. Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes. J Virol. 2004;78(3):1375\u201383.","journal-title":"J Virol"},{"key":"1082_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.576622","volume":"11","author":"L Duan","year":"2020","unstructured":"Duan L, Zheng Q, Zhang H, et al. The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccineiImmunogens. Front Immunol. 2020;11:576622.","journal-title":"Front Immunol"},{"key":"1082_CR60","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fmicb.2012.00281","volume":"3","author":"M Nomaguchi","year":"2012","unstructured":"Nomaguchi M, Fujita M, Miyazaki Y, et al. Viral tropism. Front Microbiol. 2012;3:281.","journal-title":"Front Microbiol"},{"key":"1082_CR61","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1146\/annurev.med.53.082901.104024","volume":"53","author":"JN Blankson","year":"2002","unstructured":"Blankson JN, Persaud D, Siliciano RF. The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med. 2002;53:557\u201393.","journal-title":"Annu Rev Med"},{"issue":"2","key":"1082_CR62","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1128\/jvi.65.2.736-742.1991","volume":"65","author":"CA Jordan","year":"1991","unstructured":"Jordan CA, Watkins BA, Kufta C, et al. Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent. J Virol. 1991;65(2):736\u201342.","journal-title":"J Virol"},{"issue":"8","key":"1082_CR63","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1128\/JVI.78.8.4120-4133.2004","volume":"78","author":"Y Liu","year":"2004","unstructured":"Liu Y, Liu H, Kim BO, et al. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol. 2004;78(8):4120\u201333.","journal-title":"J Virol"},{"key":"1082_CR64","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fcimb.2019.00362","volume":"9","author":"C Wallet","year":"2019","unstructured":"Wallet C, De Rovere M, Van Assche J, et al. Microglial cells: the main HIV-1 reservoir in the brain. Front Cell Infect Microbiol. 2019;9:362.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"1082_CR65","first-page":"59","volume":"50","author":"G Guzman","year":"2006","unstructured":"Guzman G, Oh S, Shukla D, et al. Expression of entry receptor nectin-1 of herpes simplex virus 1 and\/or herpes simplex virus 2 in normal and neoplastic human nervous system tissues. Acta Virol. 2006;50(1):59\u201366.","journal-title":"Acta Virol"},{"issue":"4","key":"1082_CR66","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10072-012-1026-9","volume":"34","author":"KJ Castellanos","year":"2013","unstructured":"Castellanos KJ, Gagyi E, Kormos B, et al. Increased axonal expression of nectin-1 in multiple sclerosis plaques. Neurol Sci. 2013;34(4):465\u20139.","journal-title":"Neurol Sci"},{"issue":"13","key":"1082_CR67","doi-asserted-by":"publisher","first-page":"6678","DOI":"10.1128\/JVI.00445-11","volume":"85","author":"S Pugazhenthi","year":"2011","unstructured":"Pugazhenthi S, Nair S, Velmurugan K, et al. Varicella-zoster virus infection of differentiated human neural stem cells. J Virol. 2011;85(13):6678\u201386.","journal-title":"J Virol"},{"issue":"6","key":"1082_CR68","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/pr.2014.135","volume":"76","author":"SJ Kopp","year":"2014","unstructured":"Kopp SJ, Ranaivo HR, Wilcox DR, et al. Herpes simplex virus serotype and entry receptor availability alter CNS disease in a mouse model of neonatal HSV. Pediatr Res. 2014;76(6):528\u201334.","journal-title":"Pediatr Res"},{"issue":"42","key":"1082_CR69","doi-asserted-by":"publisher","first-page":"17916","DOI":"10.1073\/pnas.0908892106","volume":"106","author":"SJ Kopp","year":"2009","unstructured":"Kopp SJ, Banisadr G, Glajch K, et al. Infection of neurons and encephalitis after intracranial inoculation of herpes simplex virus requires the entry receptor nectin-1. Proc Natl Acad Sci U S A. 2009;106(42):17916\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1082_CR70","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jneuroim.2017.03.006","volume":"308","author":"KD Shives","year":"2017","unstructured":"Shives KD, Tyler KL, Beckham JD. Molecular mechanisms of neuroinflammation and injury during acute viral encephalitis. J Neuroimmunol. 2017;308:102\u201311.","journal-title":"J Neuroimmunol"},{"issue":"9","key":"1082_CR71","doi-asserted-by":"publisher","first-page":"00111","DOI":"10.1128\/JVI.00111-19","volume":"93","author":"L D\u2019Aiuto","year":"2019","unstructured":"D'Aiuto L, Bloom DC, Naciri JN, et al. Modeling herpes simplex virus 1 infections in human central nervous system neuronal cells using two- and three-dimensional cultures derived from induced pluripotent stem cells. J Virol. 2019;93(9):00111.","journal-title":"J Virol"},{"issue":"2","key":"1082_CR72","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41579-020-00448-w","volume":"19","author":"SA Connolly","year":"2021","unstructured":"Connolly SA, Jardetzky TS, Longnecker R. The structural basis of herpesvirus entry. Nat Rev Microbiol. 2021;19(2):110\u201321.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"1082_CR73","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/NEN.0000000000000038","volume":"73","author":"N Teissier","year":"2014","unstructured":"Teissier N, Fallet-Bianco C, Delezoide A-L, et al. Cytomegalovirus-induced brain malformations in fetuses. J Neuropathol Exp Neurol. 2014;73(2):143\u201358.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"1082_CR74","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/v13061078","volume":"13","author":"F Krstanovi\u0107","year":"2021","unstructured":"Krstanovi\u0107 F, Britt WJ, Jonji\u0107 S, et al. Cytomegalovirus infection and inflammation in developing brain. Viruses. 2021;13(6):1078.","journal-title":"Viruses"},{"key":"1082_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577728","volume":"361","author":"VF Cama","year":"2021","unstructured":"Cama VF, Mar\u00edn-Prida J, Acosta-Rivero N, et al. The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: a report of three post-mortem cases. J Neuroimmunol. 2021;361:577728.","journal-title":"J Neuroimmunol"},{"issue":"11","key":"1082_CR76","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","volume":"19","author":"J Matschke","year":"2020","unstructured":"Matschke J, L\u00fctgehetmann M, Hagel C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919\u201329.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1082_CR77","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202135","volume":"218","author":"E Song","year":"2021","unstructured":"Song E, Zhang C, Israelow B, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 2021;218(3):e20202135.","journal-title":"J Exp Med"},{"key":"1082_CR78","first-page":"416","volume":"8","author":"W-B Shen","year":"2022","unstructured":"Shen W-B, Logue J, Yang P, et al. SARS-CoV-2 invades cognitive centers of the brain and induces Alzheimer\u2019s-like neuropathology. BioRxiv. 2022;8:416.","journal-title":"BioRxiv."},{"issue":"9","key":"1082_CR79","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nri2623","volume":"9","author":"G McFadden","year":"2009","unstructured":"McFadden G, Mohamed MR, Rahman MM, et al. Cytokine determinants of viral tropism. Nat Rev Immunol. 2009;9(9):645\u201355.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1082_CR80","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrmicro1099","volume":"3","author":"G McFadden","year":"2005","unstructured":"McFadden G. Poxvirus tropism. Nat Rev Microbiol. 2005;3(3):201\u201313.","journal-title":"Nat Rev Microbiol"},{"issue":"Pt 6","key":"1082_CR81","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1099\/0022-1317-81-6-1413","volume":"81","author":"J Schneider-Schaulies","year":"2000","unstructured":"Schneider-Schaulies J. Cellular receptors for viruses: links to tropism and pathogenesis. J Gen Virol. 2000;81(Pt 6):1413\u201329.","journal-title":"J Gen Virol"},{"issue":"5","key":"1082_CR82","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/nar\/25.5.925","volume":"25","author":"AM Borman","year":"1997","unstructured":"Borman AM, Le Mercier P, Girard M, et al. Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins. Nucleic Acids Res. 1997;25(5):925\u201332.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1082_CR83","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1073\/pnas.93.6.2370","volume":"93","author":"M Gromeier","year":"1996","unstructured":"Gromeier M, Alexander L, Wimmer E. Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc Natl Acad Sci U S A. 1996;93(6):2370\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1082_CR84","first-page":"51","volume":"105","author":"S Ohka","year":"2001","unstructured":"Ohka S, Nomoto A. The molecular basis of poliovirus neurovirulence. Dev Biol. 2001;105:51\u20138.","journal-title":"Dev Biol"},{"issue":"19","key":"1082_CR85","doi-asserted-by":"publisher","first-page":"10479","DOI":"10.1128\/JVI.77.19.10479-10487.2003","volume":"77","author":"A Yanagiya","year":"2003","unstructured":"Yanagiya A, Ohka S, Hashida N, et al. Tissue-specific replicating capacity of a chimeric poliovirus that carries the internal ribosome entry site of hepatitis C virus in a new mouse model transgenic for the human poliovirus receptor. J Virol. 2003;77(19):10479\u201387.","journal-title":"J Virol"},{"issue":"7","key":"1082_CR86","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0966-842X(00)01788-1","volume":"8","author":"GJ Belsham","year":"2000","unstructured":"Belsham GJ, Sonenberg N. Picornavirus RNA translation: roles for cellular proteins. Trends Microbiol. 2000;8(7):330\u20135.","journal-title":"Trends Microbiol"},{"issue":"1","key":"1082_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/jvi.71.1.1-8.1997","volume":"71","author":"K Shiroki","year":"1997","unstructured":"Shiroki K, Ishii T, Aoki T, et al. Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA. J Virol. 1997;71(1):1\u20138.","journal-title":"J Virol"},{"issue":"1","key":"1082_CR88","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1006\/viro.1993.1003","volume":"192","author":"AJ Macadam","year":"1993","unstructured":"Macadam AJ, Pollard SR, Ferguson G, et al. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology. 1993;192(1):18\u201326.","journal-title":"Virology"},{"issue":"4","key":"1082_CR89","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1073\/pnas.93.4.1412","volume":"93","author":"HH Lu","year":"1996","unstructured":"Lu HH, Wimmer E. Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus. Proc Natl Acad Sci U S A. 1996;93(4):1412\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1082_CR90","doi-asserted-by":"publisher","first-page":"4460","DOI":"10.1128\/JVI.79.7.4460-4469.2005","volume":"79","author":"M Ida-Hosonuma","year":"2005","unstructured":"Ida-Hosonuma M, Iwasaki T, Yoshikawa T, et al. The alpha\/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol. 2005;79(7):4460\u20139.","journal-title":"J Virol"},{"issue":"11","key":"1082_CR91","doi-asserted-by":"publisher","first-page":"8550","DOI":"10.1128\/JVI.72.11.8550-8558.1998","volume":"72","author":"A Garc\u00eda-Sastre","year":"1998","unstructured":"Garc\u00eda-Sastre A, Durbin RK, Zheng H, et al. The role of interferon in influenza virus tissue tropism. J Virol. 1998;72(11):8550\u20138.","journal-title":"J Virol"},{"issue":"7","key":"1082_CR92","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1128\/JVI.74.7.3366-3378.2000","volume":"74","author":"KD Ryman","year":"2000","unstructured":"Ryman KD, Klimstra WB, Nguyen KB, et al. Alpha\/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J Virol. 2000;74(7):3366\u201378.","journal-title":"J Virol"},{"key":"1082_CR93","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ijbiomac.2021.01.076","volume":"172","author":"DR Tompa","year":"2021","unstructured":"Tompa DR, Immanuel A, Srikanth S, et al. Trends and strategies to combat viral infections: a review on FDA approved antiviral drugs. Int J Biol Macromol. 2021;172:524\u201341.","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"1082_CR94","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11910-006-0048-1","volume":"6","author":"O Kincaid","year":"2006","unstructured":"Kincaid O, Lipton HL. Viral myelitis: an update. Curr Neurol Neurosci Rep. 2006;6(6):469\u201374.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"1082_CR95","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/cid\/civ373","volume":"61","author":"KL Tyler","year":"2015","unstructured":"Tyler KL. Editorial commentary: failure of adjunctive valacyclovir to improve outcomes in herpes simplex encephalitis. Clin Infect Dis. 2015;61(5):692\u20134.","journal-title":"Clin Infect Dis"},{"issue":"2\u20133","key":"1082_CR96","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0163-7258(00)00048-6","volume":"87","author":"AR Van Rompay","year":"2000","unstructured":"Van Rompay AR, Johansson M, Karlsson A. Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases. Pharmacol Ther. 2000;87(2\u20133):189\u201398.","journal-title":"Pharmacol Ther"},{"key":"1082_CR97","first-page":"1","volume-title":"antiviral nucleosides","author":"G Gumina","year":"2003","unstructured":"Gumina G, Choi Y, Chu CK. Chapter 1: Recent advances in antiviral nucleosides. In: Chu CK, editor. antiviral nucleosides. Amsterdam: Elsevier; 2003. p. 1\u201376."},{"key":"1082_CR98","doi-asserted-by":"publisher","first-page":"205873842110026","DOI":"10.1177\/20587384211002621","volume":"35","author":"S Kausar","year":"2021","unstructured":"Kausar S, Said Khan F, Ishaq Mujeeb Ur Rehman M, et al. A review: mechanism of action of antiviral drugs. Int J Immunopathol Pharmacol. 2021;35:20587384211002620.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"1082_CR99","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrd4010","volume":"12","author":"LP Jordheim","year":"2013","unstructured":"Jordheim LP, Durantel D, Zoulim F, et al. Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases. Nat Rev Drug Discov. 2013;12(6):447\u201364.","journal-title":"Nat Rev Drug Discov"},{"issue":"9305","key":"1082_CR100","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(02)07681-X","volume":"359","author":"RJ Whitley","year":"2002","unstructured":"Whitley RJ, Gnann JW. Viral encephalitis: familiar infections and emerging pathogens. Lancet. 2002;359(9305):507\u201313.","journal-title":"Lancet"},{"issue":"8","key":"1082_CR101","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1128\/JCM.43.8.4172-4174.2005","volume":"43","author":"AI Ibrahim","year":"2005","unstructured":"Ibrahim AI, Obeid MT, Jouma MJ, et al. Prevalence of herpes simplex virus (types 1 and 2), varicella-zoster virus, cytomegalovirus, and human herpesvirus 6 and 7 DNA in cerebrospinal fluid of Middle Eastern patients with encephalitis. J Clin Microbiol. 2005;43(8):4172\u20134.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"1082_CR102","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1468-1331.2010.02970.x","volume":"17","author":"I Steiner","year":"2010","unstructured":"Steiner I, Budka H, Chaudhuri A, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol. 2010;17(8):999-e57.","journal-title":"Eur J Neurol"},{"issue":"2","key":"1082_CR103","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1542\/peds.108.2.230","volume":"108","author":"DW Kimberlin","year":"2001","unstructured":"Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001;108(2):230\u20138.","journal-title":"Pediatrics"},{"issue":"7","key":"1082_CR104","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1056\/NEJM199102143240703","volume":"324","author":"R Whitley","year":"1991","unstructured":"Whitley R, Arvin A, Prober C, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med. 1991;324(7):444\u20139.","journal-title":"N Engl J Med"},{"issue":"8","key":"1082_CR105","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1469-0691.2011.03705.x","volume":"18","author":"T De Broucker","year":"2012","unstructured":"De Broucker T, Mailles A, Chabrier S, et al. Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect. 2012;18(8):808\u201319.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"1082_CR106","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1093\/cid\/ciaa185","volume":"72","author":"LK Herlin","year":"2021","unstructured":"Herlin LK, Hansen KS, Bodilsen J, et al. Varicella zoster virus encephalitis in Denmark from 2015 to 2019: a nationwide prospective cohort study. Clin Infect Dis. 2021;72(7):1192\u20139.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1082_CR107","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00705-020-04891-1","volume":"166","author":"A Kohil","year":"2021","unstructured":"Kohil A, Jemmieh S, Smatti MK, et al. Viral meningitis: an overview. Arch Virol. 2021;166(2):335\u201345.","journal-title":"Arch Virol"},{"issue":"4","key":"1082_CR108","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1055\/s-0039-1688923","volume":"39","author":"A Asundi","year":"2019","unstructured":"Asundi A, Cervantes-Arslanian AM, Lin NH, et al. Infectious myelitis. Semin Neurol. 2019;39(4):472\u201381.","journal-title":"Semin Neurol"},{"issue":"7","key":"1082_CR109","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1128\/AAC.01023-10","volume":"55","author":"T Pouplin","year":"2011","unstructured":"Pouplin T, Pouplin JN, Van Toi P, et al. Valacyclovir for herpes simplex encephalitis. Antimicrob Agents Chemother. 2011;55(7):3624\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1082_CR110","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/cid\/civ369","volume":"61","author":"JW Gnann","year":"2015","unstructured":"Gnann JW, Sk\u00f6ldenberg B, Hart J, et al. Herpes simplex encephalitis: lack of clinical benefit of long-term valacyclovir therapy. Clin Infect Dis. 2015;61(5):683\u201391.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"1082_CR111","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1086\/379520","volume":"37","author":"H Momm\u00e9ja-Marin","year":"2003","unstructured":"Momm\u00e9ja-Marin H, Lafaurie M, Scieux C, et al. Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults. Clin Infect Dis. 2003;37(11):1527\u201333.","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 3","key":"1082_CR112","doi-asserted-by":"publisher","first-page":"S294","DOI":"10.1086\/533419","volume":"197","author":"RW Price","year":"2008","unstructured":"Price RW, Spudich S. Antiretroviral therapy and central nervous system HIV type 1 infection. J Infect Dis. 2008;197(Suppl. 3):S294\u2013306.","journal-title":"J Infect Dis"},{"issue":"3","key":"1082_CR113","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ana.10827","volume":"55","author":"A d\u2019Arminio Monforte","year":"2004","unstructured":"d'Arminio Monforte A, Cinque P, Mocroft A, et al. Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol. 2004;55(3):320\u20138.","journal-title":"Ann Neurol"},{"issue":"4","key":"1082_CR114","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1212\/WNL.0000000000002277","volume":"86","author":"N Sacktor","year":"2016","unstructured":"Sacktor N, Skolasky RL, Seaberg E, et al. Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS cohort study. Neurology. 2016;86(4):334\u201340.","journal-title":"Neurology"},{"issue":"1","key":"1082_CR115","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archneurol.2007.31","volume":"65","author":"S Letendre","year":"2008","unstructured":"Letendre S, Marquie-Beck J, Capparelli E, et al. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008;65(1):65\u201370.","journal-title":"Arch Neurol"},{"issue":"2","key":"1082_CR116","first-page":"45","volume":"18","author":"SL Letendre","year":"2010","unstructured":"Letendre SL, Ellis RJ, Ances BM, et al. Neurologic complications of HIV disease and their treatment. Top HIV Med. 2010;18(2):45\u201355.","journal-title":"Top HIV Med"},{"key":"1082_CR117","volume-title":"HIV encephalitis","author":"VM Daliparty","year":"2021","unstructured":"Daliparty VM, Balasubramanya R. HIV encephalitis. Treasure Island: StatPearls Publishing LLC; 2021."},{"key":"1082_CR118","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.coph.2020.09.003","volume":"54","author":"SN Avedissian","year":"2020","unstructured":"Avedissian SN, Dyavar SR, Fox HS, et al. Pharmacologic approaches to HIV-associated neurocognitive disorders. Curr Opin Pharmacol. 2020;54:102\u20138.","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"1082_CR119","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/jac\/dkr492","volume":"67","author":"A Yilmaz","year":"2011","unstructured":"Yilmaz A, Price RW, Gissl\u00e9n M. Antiretroviral drug treatment of CNS HIV-1 infection. J Antimicrob Chemother. 2011;67(2):299\u2013311.","journal-title":"J Antimicrob Chemother"},{"issue":"14","key":"1082_CR120","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1097\/QAD.0b013e32832dc041","volume":"23","author":"K Patel","year":"2009","unstructured":"Patel K, Ming X, Williams PL, et al. Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS. 2009;23(14):1893\u2013901.","journal-title":"AIDS"},{"key":"1082_CR121","doi-asserted-by":"crossref","unstructured":"Sadowski LA, Upadhyay R, Greeley ZW, et al. Current drugs to treat infections with herpes simplex viruses-1 and -2. Viruses. 2021;13(7).","DOI":"10.3390\/v13071228"},{"issue":"3","key":"1082_CR122","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/1389200217666151210141903","volume":"17","author":"A Varga","year":"2016","unstructured":"Varga A, Lionne C, Roy B. Intracellular metabolism of nucleoside\/nucleotide analogues: a bottleneck to reach active drugs on HIV reverse transcriptase. Curr Drug Metab. 2016;17(3):237\u201352.","journal-title":"Curr Drug Metab"},{"key":"1082_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.616863","volume":"8","author":"E Groaz","year":"2020","unstructured":"Groaz E, De Jonghe S. Overview of biologically active nucleoside phosphonates. Front Chem. 2020;8: 616863.","journal-title":"Front Chem"},{"key":"1082_CR124","doi-asserted-by":"publisher","first-page":"204020661877524","DOI":"10.1177\/2040206618775243","volume":"26","author":"M Slusarczyk","year":"2018","unstructured":"Slusarczyk M, Serpi M, Pertusati F. Phosphoramidates and phosphonamidates (ProTides) with antiviral activity. Antiviral Chem Chemother. 2018;26:2040206618775243.","journal-title":"Antiviral Chem Chemother"},{"issue":"23","key":"1082_CR125","doi-asserted-by":"publisher","first-page":"10400","DOI":"10.1021\/acs.jmedchem.6b00523","volume":"59","author":"PJ Thornton","year":"2016","unstructured":"Thornton PJ, Kadri H, Miccoli A, et al. Nucleoside phosphate and phosphonate prodrug clinical candidates. J Med Chem. 2016;59(23):10400\u201310.","journal-title":"J Med Chem"},{"issue":"15","key":"1082_CR126","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1097\/QAD.0000000000001189","volume":"30","author":"KR Robertson","year":"2016","unstructured":"Robertson KR, Miyahara S, Lee A, et al. Neurocognition with maraviroc compared with tenofovir in HIV. AIDS. 2016;30(15):2315\u201321.","journal-title":"AIDS"},{"issue":"6","key":"1082_CR127","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/cid\/cis507","volume":"55","author":"K Robertson","year":"2012","unstructured":"Robertson K, Jiang H, Kumwenda J, et al. Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study. Clin Infect Dis. 2012;55(6):868\u201376.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1082_CR128","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/cid\/ciz926","volume":"71","author":"Q Ma","year":"2020","unstructured":"Ma Q, Ocque AJ, Morse GD, et al. Switching to tenofovir alafenamide in elvitegravir-based regimens: pharmacokinetics and antiviral activity in cerebrospinal fluid. Clin Infect Dis. 2020;71(4):982\u20138.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1082_CR129","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/cts.12661","volume":"12","author":"MR Nicol","year":"2019","unstructured":"Nicol MR, Pastick KA, Taylor J, et al. Cerebrospinal fluid and brain tissue penetration of tenofovir, lamivudine, and efavirenz in postmortem tissues with cryptococcal meningitis. Clin Transl Sci. 2019;12(5):445\u20139.","journal-title":"Clin Transl Sci"},{"key":"1082_CR130","doi-asserted-by":"publisher","first-page":"1012884","DOI":"10.3389\/fimmu.2022.1012884","volume":"13","author":"HS Fox","year":"2022","unstructured":"Fox HS, Niu M, Morsey BM, et al. Morphine suppresses peripheral responses and transforms brain myeloid gene expression to favor neuropathogenesis in SIV infection. Front Immunol. 2022;13:1012884.","journal-title":"Front Immunol"},{"key":"1082_CR131","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.coviro.2021.04.014","volume":"49","author":"M G\u00f6tte","year":"2021","unstructured":"G\u00f6tte M. Remdesivir for the treatment of COVID-19: the value of biochemical studies. Curr Opin Virol. 2021;49:81\u20135.","journal-title":"Curr Opin Virol"},{"issue":"1","key":"1082_CR132","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1038\/s41467-022-33825-5","volume":"13","author":"OPO Nevalainen","year":"2022","unstructured":"Nevalainen OPO, Horstia S, Laakkonen S, et al. Effect of remdesivir post hospitalization for COVID-19 infection from the randomized SOLIDARITY Finland trial. Nat Commun. 2022;13(1):6152.","journal-title":"Nat Commun"},{"issue":"25","key":"1082_CR133","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","volume":"383","author":"DA Berlin","year":"2020","unstructured":"Berlin DA, Gulick RM, Martinez FJ. Severe COVID-19. N Engl J Med. 2020;383(25):2451\u201360.","journal-title":"N Engl J Med"},{"key":"1082_CR134","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/B978-0-12-405880-4.00003-2","volume":"67","author":"M M\u00e9tifiot","year":"2013","unstructured":"M\u00e9tifiot M, Marchand C, Pommier Y. HIV integrase inhibitors: 20-year landmark and challenges. Adv Pharmacol. 2013;67:75\u2013105.","journal-title":"Adv Pharmacol"},{"issue":"9","key":"1082_CR135","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.tips.2020.06.003","volume":"41","author":"IK J\u00f3\u017awik","year":"2020","unstructured":"J\u00f3\u017awik IK, Passos DO, Lyumkis D. Structural biology of HIV integrase strand transfer inhibitors. Trends Pharmacol Sci. 2020;41(9):611\u201326.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"1082_CR136","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12977-022-00608-1","volume":"19","author":"AV Zhao","year":"2022","unstructured":"Zhao AV, Crutchley RD, Guduru RC, et al. A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection. Retrovirology. 2022;19(1):22.","journal-title":"Retrovirology"},{"issue":"1","key":"1082_CR137","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.2022.22246","volume":"329","author":"RT Gandhi","year":"2023","unstructured":"Gandhi RT, Bedimo R, Hoy JF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society-USA Panel. JAMA. 2023;329(1):63\u201384.","journal-title":"JAMA"},{"issue":"6","key":"1082_CR138","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz174","volume":"6","author":"T Gel\u00e9","year":"2019","unstructured":"Gel\u00e9 T, Furlan V, Taburet AM, et al. Dolutegravir cerebrospinal fluid diffusion in HIV-1-infected patients with central nervous system impairment. Open Forum Infect Dis. 2019;6(6):ofz174.","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"1082_CR139","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/cid\/ciu477","volume":"59","author":"SL Letendre","year":"2014","unstructured":"Letendre SL, Mills AM, Tashima KT, et al. ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects. Clin Infect Dis. 2014;59(7):1032\u20137.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1082_CR140","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/infdis\/jiz624","volume":"221","author":"J Tiraboschi","year":"2020","unstructured":"Tiraboschi J, Imaz A, Khoo S, et al. Total and unbound bictegravir concentrations and viral suppression in cerebrospinal fluid of human immunodeficiency virus-infected patients (Spanish HIV\/AIDS Research Network, PreEC\/RIS 56). J Infect Dis. 2020;221(9):1425\u20138.","journal-title":"J Infect Dis"},{"issue":"5","key":"1082_CR141","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s43440-023-00515-y","volume":"75","author":"A Jakimiuk","year":"2023","unstructured":"Jakimiuk A, Piechal A, Wierci\u0144ska-Drapa\u0142o A, et al. Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies. Pharmacol Rep. 2023;75(5):1138\u201351.","journal-title":"Pharmacol Rep"},{"issue":"1","key":"1082_CR142","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11481-020-09904-z","volume":"15","author":"Q Ma","year":"2020","unstructured":"Ma Q, Schifitto G, Venuto C, et al. Effect of dolutegravir and sertraline on the blood brain barrier (BBB). J Neuroimmune Pharmacol. 2020;15(1):7\u20139.","journal-title":"J Neuroimmune Pharmacol"},{"key":"1082_CR143","doi-asserted-by":"publisher","first-page":"1118580","DOI":"10.3389\/fphar.2023.1118580","volume":"14","author":"C Huang","year":"2023","unstructured":"Huang C, Hoque T, Bendayan R. Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood\u2013brain barrier integrity and function. Front Pharmacol. 2023;14:1118580.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1082_CR144","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1128\/AAC.00615-10","volume":"55","author":"J Piret","year":"2011","unstructured":"Piret J, Boivin G. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother. 2011;55(2):459\u201372.","journal-title":"Antimicrob Agents Chemother"},{"key":"1082_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104012","volume":"141","author":"T Azimi","year":"2020","unstructured":"Azimi T, Tavakolian S, Goudarzi H, et al. Global estimate of phenotypic and genotypic ganciclovir resistance in cytomegalovirus infections among HIV and organ transplant patients; a systematic review and meta-analysis. Microb Pathog. 2020;141:104012.","journal-title":"Microb Pathog"},{"issue":"11","key":"1082_CR146","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","volume":"32","author":"WM Pardridge","year":"2012","unstructured":"Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012;32(11):1959\u201372.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Suppl 1","key":"1082_CR147","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1471-2377-9-S1-S3","volume":"9","author":"WA Banks","year":"2009","unstructured":"Banks WA. Characteristics of compounds that cross the blood-brain barrier. BMC Neurol. 2009;9(Suppl 1):S3.","journal-title":"BMC Neurol"},{"issue":"8","key":"1082_CR148","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1128\/AAC.47.8.2438-2441.2003","volume":"47","author":"J Lycke","year":"2003","unstructured":"Lycke J, Malmestr\u00f6m C, St\u00e5hle L. Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir. Antimicrob Agents Chemother. 2003;47(8):2438\u201341.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1a","key":"1082_CR149","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0002-9343(82)90084-5","volume":"73","author":"RJ Whitley","year":"1982","unstructured":"Whitley RJ, Blum MR, Barton N, et al. Pharmacokinetics of acyclovir in humans following intravenous administration: a model for the development of parenteral antivirals. Am J Med. 1982;73(1a):165\u201371.","journal-title":"Am J Med"},{"issue":"4","key":"1082_CR150","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/jcph.612","volume":"56","author":"CD Lahiri","year":"2016","unstructured":"Lahiri CD, Reed-Walker K, Sheth AN, et al. Cerebrospinal fluid concentrations of tenofovir and emtricitabine in the setting of HIV-1 protease inhibitor-based regimens. J Clin Pharmacol. 2016;56(4):492\u20136.","journal-title":"J Clin Pharmacol"},{"issue":"13","key":"1082_CR151","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2217\/nnm-2022-0043","volume":"17","author":"CR Garcia","year":"2022","unstructured":"Garcia CR, Rad AT, Saeedinejad F, et al. Effect of drug-to-lipid ratio on nanodisc-based tenofovir drug delivery to the brain for HIV-1 infection. Nanomedicine. 2022;17(13):959\u201378.","journal-title":"Nanomedicine"},{"key":"1082_CR152","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/bs.apha.2014.06.010","volume":"71","author":"T Ashraf","year":"2014","unstructured":"Ashraf T, Kao A, Bendayan R. Functional expression of drug transporters in glial cells: potential role on drug delivery to the CNS. Adv Pharmacol. 2014;71:45\u2013111.","journal-title":"Adv Pharmacol"},{"issue":"1","key":"1082_CR153","first-page":"F122","volume":"276","author":"M Hosoyamada","year":"1999","unstructured":"Hosoyamada M, Sekine T, Kanai Y, et al. Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol. 1999;276(1):F122-8.","journal-title":"Am J Physiol"},{"issue":"1","key":"1082_CR154","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1124\/dmd.111.041145","volume":"40","author":"J Naud","year":"2012","unstructured":"Naud J, Laurin L-P, Michaud J, et al. Effects of chronic renal failure on brain drug transporters in rats. Drug Metab Dispos. 2012;40(1):39\u201346.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"1082_CR155","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/01.WCB.0000050062.57184.75","volume":"23","author":"S Mori","year":"2003","unstructured":"Mori S, Takanaga H, Ohtsuki S, et al. Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J Cerebral Blood Flow Metab. 2003;23(4):432\u201340.","journal-title":"J Cerebral Blood Flow Metab."},{"issue":"5","key":"1082_CR156","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1124\/mol.59.5.1277","volume":"59","author":"SH Cha","year":"2001","unstructured":"Cha SH, Sekine T, Fukushima JI, et al. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol. 2001;59(5):1277\u201386.","journal-title":"Mol Pharmacol"},{"issue":"1","key":"1082_CR157","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1124\/jpet.108.146225","volume":"329","author":"G Minuesa","year":"2009","unstructured":"Minuesa G, Volk C, Molina-Arcas M, et al. Transport of lamivudine [(-)-beta-L-2\u2019,3\u2019-dideoxy-3\u2019-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3. J Pharmacol Exp Ther. 2009;329(1):252\u201361.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1082_CR158","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.tiv.2014.10.019","volume":"29","author":"X Zhang","year":"2015","unstructured":"Zhang X, Wang R, Piotrowski M, et al. Intracellular concentrations determine the cytotoxicity of adefovir, cidofovir and tenofovir. Toxicol In Vitro. 2015;29(1):251\u20138.","journal-title":"Toxicol In Vitro"},{"issue":"2","key":"1082_CR159","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S1734-1140(13)71026-0","volume":"65","author":"J Ye","year":"2013","unstructured":"Ye J, Liu Q, Wang C, et al. Benzylpenicillin inhibits the renal excretion of acyclovir by OAT1 and OAT3. Pharmacol Rep. 2013;65(2):505\u201312.","journal-title":"Pharmacol Rep"},{"issue":"5","key":"1082_CR160","doi-asserted-by":"publisher","first-page":"C1075","DOI":"10.1152\/ajpcell.00619.2004","volume":"289","author":"A Bahn","year":"2005","unstructured":"Bahn A, Ljubojevic M, Lorenz H, et al. Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites. Am J Physiol Cell Physiol. 2005;289(5):C1075-84.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1082_CR161","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuroscience.2015.07.055","volume":"304","author":"N Oshima","year":"2015","unstructured":"Oshima N, Onimaru H, Matsubara H, et al. Uric acid, indoxyl sulfate, and methylguanidine activate bulbospinal neurons in the RVLM via their specific transporters and by producing oxidative stress. Neuroscience. 2015;304:133\u201345.","journal-title":"Neuroscience"},{"issue":"3","key":"1082_CR162","first-page":"844","volume":"294","author":"S Wada","year":"2000","unstructured":"Wada S, Tsuda M, Sekine T, et al. Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs. J Pharmacol Exp Ther. 2000;294(3):844\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"1082_CR163","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1124\/jpet.102.046847","volume":"305","author":"M Hasegawa","year":"2003","unstructured":"Hasegawa M, Kusuhara H, Endou H, et al. Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat. J Pharmacol Exp Ther. 2003;305(3):1087\u201397.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"1082_CR164","first-page":"184","volume":"18","author":"B Aloy","year":"2016","unstructured":"Aloy B, Tazi I, Bagnis CI, et al. Is tenofovir alafenamide safer than tenofovir disoproxil fumarate for the kidneys? AIDS Rev. 2016;18(4):184\u201392.","journal-title":"AIDS Rev"},{"issue":"3","key":"1082_CR165","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1124\/jpet.300.3.918","volume":"300","author":"M Takeda","year":"2002","unstructured":"Takeda M, Khamdang S, Narikawa S, et al. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002;300(3):918\u201324.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"1082_CR166","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s00429-016-1315-9","volume":"222","author":"PJ Gasser","year":"2017","unstructured":"Gasser PJ, Hurley MM, Chan J, et al. Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice. Brain Struct Funct. 2017;222(4):1913\u201328.","journal-title":"Brain Struct Funct"},{"issue":"6","key":"1082_CR167","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/glia.22484","volume":"61","author":"T Yoshikawa","year":"2013","unstructured":"Yoshikawa T, Naganuma F, Iida T, et al. Molecular mechanism of histamine clearance by primary human astrocytes. Glia. 2013;61(6):905\u201316.","journal-title":"Glia"},{"issue":"2","key":"1082_CR168","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/mol.54.2.342","volume":"54","author":"AE Busch","year":"1998","unstructured":"Busch AE, Karbach U, Miska D, et al. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol. 1998;54(2):342\u201352.","journal-title":"Mol Pharmacol"},{"issue":"7","key":"1082_CR169","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3390\/pharmaceutics14071501","volume":"14","author":"PT Ronaldson","year":"2022","unstructured":"Ronaldson PT, Davis TP. Transport mechanisms at the blood-brain barrier and in cellular compartments of the neurovascular unit: focus on CNS delivery of small molecule drugs. Pharmaceutics. 2022;14(7):1501.","journal-title":"Pharmaceutics"},{"issue":"6","key":"1082_CR170","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/j.1528-1167.2005.66604.x","volume":"46","author":"E Aronica","year":"2005","unstructured":"Aronica E, Gorter JA, Redeker S, et al. Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain. Epilepsia. 2005;46(6):849\u201357.","journal-title":"Epilepsia"},{"issue":"4","key":"1082_CR171","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1055\/s-0028-1103272","volume":"39","author":"M Daood","year":"2008","unstructured":"Daood M, Tsai C, Ahdab-Barmada M, et al. ABC transporter (P-gp\/ABCB1, MRP1\/ABCC1, BCRP\/ABCG2) expression in the developing human CNS. Neuropediatrics. 2008;39(4):211\u20138.","journal-title":"Neuropediatrics"},{"issue":"10","key":"1082_CR172","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/j.1528-1167.2005.00250.x","volume":"46","author":"EA van Vliet","year":"2005","unstructured":"van Vliet EA, Redeker S, Aronica E, et al. Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats. Epilepsia. 2005;46(10):1569\u201380.","journal-title":"Epilepsia"},{"issue":"7","key":"1082_CR173","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1007\/s11095-007-9244-1","volume":"24","author":"G Lee","year":"2007","unstructured":"Lee G, Babakhanian K, Ramaswamy M, et al. Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems. Pharm Res. 2007;24(7):1262\u201374.","journal-title":"Pharm Res"},{"issue":"1","key":"1082_CR174","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1124\/jpet.103.054304","volume":"307","author":"S Dallas","year":"2003","unstructured":"Dallas S, Zhu X, Baruchel S, et al. Functional expression of the multidrug resistance protein 1 in microglia. J Pharmacol Exp Ther. 2003;307(1):282\u201390.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"1082_CR175","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/(SICI)1097-4547(20000601)60:5<594::AID-JNR4>3.0.CO;2-6","volume":"60","author":"X Decl\u00e8ves","year":"2000","unstructured":"Decl\u00e8ves X, Regina A, Laplanche JL, et al. Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes. J Neurosci Res. 2000;60(5):594\u2013601.","journal-title":"J Neurosci Res"},{"issue":"3","key":"1082_CR176","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1046\/j.1471-4159.2002.01082.x","volume":"82","author":"J Hirrlinger","year":"2002","unstructured":"Hirrlinger J, K\u00f6nig J, Dringen R. Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones. J Neurochem. 2002;82(3):716\u20139.","journal-title":"J Neurochem"},{"issue":"2","key":"1082_CR177","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.neuroscience.2004.07.051","volume":"129","author":"AT Nies","year":"2004","unstructured":"Nies AT, Jedlitschky G, K\u00f6nig J, et al. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience. 2004;129(2):349\u201360.","journal-title":"Neuroscience"},{"issue":"10","key":"1082_CR178","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1369\/jhc.5A6870.2006","volume":"54","author":"R Bendayan","year":"2006","unstructured":"Bendayan R, Ronaldson PT, Gingras D,et al. In situ localization of P-glycoprotein (ABCB1) in human and rat brain. J Histochem Cytochem. 2006;54(10):1159\u201367.","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"1082_CR179","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.neuroscience.2003.10.012","volume":"123","author":"HA Volk","year":"2004","unstructured":"Volk HA, Burkhardt K, Potschka H, et al. Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures. Neuroscience. 2004;123(3):751\u20139.","journal-title":"Neuroscience"},{"key":"1082_CR180","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mad.2014.08.003","volume":"141\u2013142","author":"HG Bernstein","year":"2014","unstructured":"Bernstein HG, H\u00f6lzl G, Dobrowolny H, et al. Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary. Mech Ageing Dev. 2014;141\u2013142:12\u201321.","journal-title":"Mech Ageing Dev"},{"issue":"5","key":"1082_CR181","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/COH.0b013e328356e91c","volume":"7","author":"JL Adams","year":"2012","unstructured":"Adams JL, Greener BN, Kashuba ADM. Pharmacology of HIV integrase inhibitors. Curr Opin HIV AIDS. 2012;7(5):390\u2013400.","journal-title":"Curr Opin HIV AIDS"},{"issue":"6","key":"1082_CR182","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2217\/pgs.10.70","volume":"11","author":"E Errasti-Murugarren","year":"2010","unstructured":"Errasti-Murugarren E, Pastor-Anglada M. Drug transporter pharmacogenetics in nucleoside-based therapies. Pharmacogenomics. 2010;11(6):809\u201341.","journal-title":"Pharmacogenomics"},{"key":"1082_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134475","volume":"712","author":"SH Patel","year":"2019","unstructured":"Patel SH, Ismaiel OA, Mylott WR, et al. Cell-type specific differences in antiretroviral penetration and the effects of HIV-1 Tat and morphine among primary human brain endothelial cells, astrocytes, pericytes, and microglia. Neurosci Lett. 2019;712:134475.","journal-title":"Neurosci Lett"},{"issue":"4","key":"1082_CR184","first-page":"263","volume":"4","author":"AM McDonnell","year":"2013","unstructured":"McDonnell AM, Dang CH. Basic review of the cytochrome p450 system. J Adv Pract Oncol. 2013;4(4):263\u20138.","journal-title":"J Adv Pract Oncol"},{"issue":"27","key":"1082_CR185","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.2174\/0929867325666180226111311","volume":"25","author":"ECC Mano","year":"2018","unstructured":"Mano ECC, Scott AL, Honorio KM. UDP-glucuronosyltransferases: structure, function and drug design studies. Curr Med Chem. 2018;25(27):3247\u201355.","journal-title":"Curr Med Chem"},{"issue":"1","key":"1082_CR186","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138(1):103\u201341.","journal-title":"Pharmacol Ther"},{"key":"1082_CR187","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3389\/fncel.2014.00349","volume":"8","author":"M Ouzzine","year":"2014","unstructured":"Ouzzine M, Gulberti S, Ramalanjaona N, et al. The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication. Front Cell Neurosci. 2014;8:349.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"1082_CR188","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0006-8993(99)02354-9","volume":"855","author":"P Voirol","year":"2000","unstructured":"Voirol P, Jonzier-Perey M, Porchet F, et al. Cytochrome P-450 activities in human and rat brain microsomes. Brain Res. 2000;855(2):235\u201343.","journal-title":"Brain Res"},{"issue":"1","key":"1082_CR189","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/004982597240802","volume":"27","author":"DE Gilham","year":"1997","unstructured":"Gilham DE, Cairns W, Paine MJ, et al. Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain by in situ hybridization. Xenobiotica. 1997;27(1):111\u201325.","journal-title":"Xenobiotica"},{"issue":"3","key":"1082_CR190","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1528-1167.2010.02956.x","volume":"52","author":"C Ghosh","year":"2011","unstructured":"Ghosh C, Marchi N, Desai NK, et al. Cellular localization and functional significance of CYP3A4 in the human epileptic brain. Epilepsia. 2011;52(3):562\u201371.","journal-title":"Epilepsia"},{"issue":"2","key":"1082_CR191","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0304-3959(88)90219-9","volume":"35","author":"A Wahlstr\u00f6m","year":"1988","unstructured":"Wahlstr\u00f6m A, Winblad B, Bixo M, et al. Human brain metabolism of morphine and naloxone. Pain. 1988;35(2):121\u20137.","journal-title":"Pain"},{"issue":"8","key":"1082_CR192","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1128\/AAC.00292-13","volume":"57","author":"S Castellino","year":"2013","unstructured":"Castellino S, Moss L, Wagner D, et al. Metabolism, excretion, and mass balance of the HIV-1 integrase inhibitor dolutegravir in humans. Antimicrob Agents Chemother. 2013;57(8):3536\u201346.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1082_CR193","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00204-014-1394-4","volume":"90","author":"SE Gambaro","year":"2016","unstructured":"Gambaro SE, Robert MC, Tiribelli C, et al. Role of brain cytochrome P450 mono-oxygenases in bilirubin oxidation-specific induction and activity. Arch Toxicol. 2016;90(2):279\u201390.","journal-title":"Arch Toxicol"},{"issue":"1","key":"1082_CR194","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1208\/s12248-020-00536-y","volume":"23","author":"L Di","year":"2021","unstructured":"Di L, Balesano A, Jordan S, et al. The role of alcohol dehydrogenase in drug metabolism: beyond ethanol oxidation. AAPS J. 2021;23(1):20.","journal-title":"AAPS J"},{"issue":"19","key":"1082_CR195","first-page":"5045","volume":"268","author":"SE Mart\u00ednez","year":"2001","unstructured":"Mart\u00ednez SE, Vaglenova J, Sabri\u00e0 J, et al. Distribution of alcohol dehydrogenase mRNA in the rat central nervous system: consequences for brain ethanol and retinoid metabolism. Eur J Biochem. 2001;268(19):5045\u201356.","journal-title":"Eur J Biochem"},{"issue":"3849","key":"1082_CR196","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1126\/science.162.3849.131","volume":"162","author":"NH Raskin","year":"1968","unstructured":"Raskin NH, Sokoloff L. Brain alcohol dehydrogenase. Science. 1968;162(3849):131\u20132.","journal-title":"Science"},{"issue":"2","key":"1082_CR197","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.idc.2010.01.001","volume":"24","author":"L Strasfeld","year":"2010","unstructured":"Strasfeld L, Chou S. Antiviral drug resistance: mechanisms and clinical implications. Infect Dis Clin N Am. 2010;24(2):413\u201337.","journal-title":"Infect Dis Clin N Am"},{"issue":"5","key":"1082_CR198","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0002-9459(24)07757-X","volume":"70","author":"MM Zdanowicz","year":"2006","unstructured":"Zdanowicz MM. The pharmacology of HIV drug resistance. Am J Pharm Educ. 2006;70(5):100.","journal-title":"Am J Pharm Educ"},{"issue":"1","key":"1082_CR199","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1128\/CMR.16.1.114-128.2003","volume":"16","author":"TH Bacon","year":"2003","unstructured":"Bacon TH, Levin MJ, Leary JJ, et al. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev. 2003;16(1):114\u201328.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"1082_CR200","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1128\/CMR.00009-10","volume":"23","author":"NS Lurain","year":"2010","unstructured":"Lurain NS, Chou S. Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev. 2010;23(4):689\u2013712.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"1082_CR201","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1086\/314052","volume":"31","author":"Y Chen","year":"2000","unstructured":"Chen Y, Scieux C, Garrait V, et al. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. Clin Infect Dis. 2000;31(4):927\u201335.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1082_CR202","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1086\/432477","volume":"41","author":"DL Wyles","year":"2005","unstructured":"Wyles DL, Patel A, Madinger N, et al. Development of herpes simplex virus disease in patients who are receiving cidofovir. Clin Infect Dis. 2005;41(5):676\u201380.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1082_CR203","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1128\/AAC.42.9.2240","volume":"42","author":"DA Jabs","year":"1998","unstructured":"Jabs DA, Enger C, Forman M, et al. Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis: the Cytomegalovirus Retinitis and Viral Resistance Study Group. Antimicrob Agents Chemother. 1998;42(9):2240\u20134.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1082_CR204","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/infdis\/jiaa683","volume":"224","author":"S Bertagnolio","year":"2021","unstructured":"Bertagnolio S, Hermans L, Jordan MR, et al. Clinical impact of pretreatment human immunodeficiency virus drug resistance in people initiating nonnucleoside reverse transcriptase inhibitor-containing antiretroviral therapy: a systematic review and meta-analysis. J Infect Dis. 2021;224(3):377\u201388.","journal-title":"J Infect Dis"},{"key":"1082_CR205","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.eclinm.2019.03.006","volume":"9","author":"B Chimukangara","year":"2019","unstructured":"Chimukangara B, Lessells RJ, Rhee SY, et al. Trends in pretreatment HIV-1 drug resistance in antiretroviral therapy-naive adults in South Africa, 2000\u20132016: a pooled sequence analysis. EClinicalMedicine. 2019;9:26\u201334.","journal-title":"EClinicalMedicine."},{"issue":"1","key":"1082_CR206","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12981-020-00282-3","volume":"17","author":"F Neuhann","year":"2020","unstructured":"Neuhann F, de Forest A, Heger E, et al. Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi. AIDS Res Ther. 2020;17(1):22.","journal-title":"AIDS Res Ther"},{"issue":"4","key":"1082_CR207","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1034\/j.1399-3062.2002.02005.x","volume":"4","author":"JE Julin","year":"2002","unstructured":"Julin JE, van Burik JH, Krivit W, et al. Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient. Transpl Infect Dis. 2002;4(4):201\u20136.","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"1082_CR208","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s13365-016-0489-5","volume":"23","author":"M Bergmann","year":"2017","unstructured":"Bergmann M, Beer R, Kofler M, et al. Acyclovir resistance in herpes simplex virus type I encephalitis: a case report. J Neurovirol. 2017;23(2):335\u20137.","journal-title":"J Neurovirol"},{"issue":"6","key":"1082_CR209","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1177\/0956462418824905","volume":"30","author":"M Hlebowicz","year":"2019","unstructured":"Hlebowicz M, Parczewski M, Jakubowski P. HIV encephalitis in a patient on antiretroviral therapy: a case report. Int J STD AIDS. 2019;30(6):617\u20139.","journal-title":"Int J STD AIDS"},{"issue":"1","key":"1082_CR210","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/aid.2011.0020","volume":"28","author":"P Tamarit Mdel","year":"2012","unstructured":"Tamarit Mdel P, Quereda C, Gonzalez-Rozas M, et al. HIV type 1 viral encephalitis after development of viral resistance to plasma suppressive antiretroviral therapy. AIDS Res Hum Retroviruses. 2012;28(1):83\u20136.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"18","key":"1082_CR211","doi-asserted-by":"publisher","first-page":"10133","DOI":"10.1128\/JVI.78.18.10133-10148.2004","volume":"78","author":"TK Smit","year":"2004","unstructured":"Smit TK, Brew BJ, Tourtellotte W, et al. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. J Virol. 2004;78(18):10133\u201348.","journal-title":"J Virol"},{"issue":"5","key":"1082_CR212","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10928-021-09768-7","volume":"48","author":"MAA Saleh","year":"2021","unstructured":"Saleh MAA, Loo CF, Elassaiss-Schaap J, et al. Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3.0 simulations. J Pharmacokinet Pharmacodyn. 2021;48(5):725\u201341.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"1082_CR213","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/FTD.0000000000000925","volume":"44","author":"A-G M\u00e4rtson","year":"2022","unstructured":"M\u00e4rtson A-G, Edwina AE, Kim HY, et al. Therapeutic drug monitoring of ganciclovir: where are we? Ther Drug Monitor. 2022;44(1):138\u201347.","journal-title":"Ther Drug Monitor."},{"issue":"6","key":"1082_CR214","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/17425255.2021.1915285","volume":"17","author":"A Calcagno","year":"2021","unstructured":"Calcagno A, Trunfio M, D'Avolio A, et al. The impact of age on antiretroviral drug pharmacokinetics in the treatment of adults living with HIV. Expert Opin Drug Metabol Toxicol. 2021;17(6):665\u201376.","journal-title":"Expert Opin Drug Metabol Toxicol"},{"issue":"9","key":"1082_CR215","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1128\/AAC.00593-11","volume":"55","author":"L Wang","year":"2011","unstructured":"Wang L, Soon GH, Seng K-Y, et al. Pharmacokinetic modeling of plasma and intracellular concentrations of raltegravir in healthy volunteers. Antimicrob Agents Chemother. 2011;55(9):4090\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1082_CR216","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/jcph.461","volume":"55","author":"RN Burns","year":"2015","unstructured":"Burns RN, Hendrix CW, Chaturvedula A. Population pharmacokinetics of tenofovir and tenofovir-diphosphate in healthy women. J Clin Pharmacol. 2015;55(6):629\u201338.","journal-title":"J Clin Pharmacol"},{"issue":"8","key":"1082_CR217","first-page":"10","volume":"61","author":"A Habtewold","year":"2017","unstructured":"Habtewold A, Aklillu E, Makonnen E, et al. Population pharmacokinetic model linking plasma and peripheral blood mononuclear cell concentrations of efavirenz and its metabolite, 8-hydroxy-efavirenz. HIV patients Antimicrobial Agents Chemother. 2017;61(8):10\u20131128.","journal-title":"HIV patients. Antimicrobial Agents Chemother."},{"issue":"8","key":"1082_CR218","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1128\/AAC.44.8.2173-2175.2000","volume":"44","author":"SL Letendre","year":"2000","unstructured":"Letendre SL, Capparelli EV, Ellis RJ, et al. Indinavir population pharmacokinetics in plasma and cerebrospinal fluid. The HIV Neurobehavioral Research Center Group. Antimicrob Agents Chemother. 2000;44(8):2173\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1082_CR219","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijantimicag.2014.12.016","volume":"45","author":"SKB Sy","year":"2015","unstructured":"Sy SKB, Malmberg R, Matsushima A, et al. Effect of reducing the paediatric stavudine dose by half: a physiologically-based pharmacokinetic model. Int J Antimicrob Agents. 2015;45(4):413\u20139.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"1082_CR220","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/cts.12975","volume":"14","author":"JM Gallo","year":"2021","unstructured":"Gallo JM. Hybrid physiologically-based pharmacokinetic model for remdesivir: application to SARS-CoV-2. Clin Transl Sci. 2021;14(3):1082\u201391.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"1082_CR221","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1208\/s12248-016-9992-0","volume":"19","author":"M Ito","year":"2017","unstructured":"Ito M, Kusuhara H, Ose A, et al. Pharmacokinetic modeling and Monte Carlo simulation to predict interindividual variability in human exposure to oseltamivir and its active metabolite, Ro 64\u20130802. AAPS J. 2017;19(1):286\u201397.","journal-title":"AAPS J"},{"issue":"1","key":"1082_CR222","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/pharmaceutics6010097","volume":"6","author":"RK Badhan","year":"2014","unstructured":"Badhan RK, Chenel M, Penny JI. Development of a physiologically-based pharmacokinetic model of the rat central nervous system. Pharmaceutics. 2014;6(1):97\u2013136.","journal-title":"Pharmaceutics"},{"issue":"4","key":"1082_CR223","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s11095-015-1846-4","volume":"33","author":"M Johnson","year":"2016","unstructured":"Johnson M, Kozielska M, Pilla Reddy V, et al. Translational modeling in schizophrenia: predicting human dopamine D2 receptor occupancy. Pharm Res. 2016;33(4):1003\u201317.","journal-title":"Pharm Res"},{"issue":"3","key":"1082_CR224","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.dmpk.2016.03.005","volume":"31","author":"L Gaohua","year":"2016","unstructured":"Gaohua L, Neuhoff S, Johnson TN, et al. Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: estimating time varying CSF drug concentrations and their variability using in vitro data. Drug Metab Pharmacokinet. 2016;31(3):224\u201333.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"1082_CR225","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics10010014","volume":"10","author":"Z Zakaria","year":"2018","unstructured":"Zakaria Z, Badhan R. Development of a region-specific physiologically based pharmacokinetic brain model to assess hippocampus and frontal cortex pharmacokinetics. Pharmaceutics. 2018;10(1):1\u201314.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1082_CR226","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/pharmaceutics13010095","volume":"13","author":"MAA Saleh","year":"2021","unstructured":"Saleh MAA, de Lange ECM. Impact of CNS diseases on drug delivery to brain extracellular and intracellular target sites in human: a \u201cWHAT-IF\u201d simulation study. Pharmaceutics. 2021;13(1):95.","journal-title":"Pharmaceutics"},{"key":"1082_CR227","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106345","volume":"181","author":"MAA Saleh","year":"2023","unstructured":"Saleh MAA, Hirasawa M, Sun M, et al. The PBPK LeiCNS-PK3.0 framework predicts nirmatrelvir (but not remdesivir or molnupiravir) to achieve effective concentrations against SARS-CoV-2 in human brain cells. Eur J Pharm Sci. 2023;181:106345.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"1082_CR228","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1124\/jpet.122.001256","volume":"383","author":"AM Heitman","year":"2022","unstructured":"Heitman AM, Bies RR, Schwartz SL. A physiologically-based pharmacokinetic model of the brain considering regional lipid variance. J Pharmacol Exp Ther. 2022;383(3):217\u201326.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"1082_CR229","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","volume":"48","author":"OP Soldin","year":"2009","unstructured":"Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009;48(3):143\u201357.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"1082_CR230","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1021\/acsptsci.3c00116","volume":"7","author":"M Courchesne","year":"2024","unstructured":"Courchesne M, Manrique G, Bernier L, et al. Gender differences in pharmacokinetics: a perspective on contrast agents. ACS Pharmacol Transl Sci. 2024;7(1):8\u201317.","journal-title":"ACS Pharmacol Transl Sci."},{"issue":"5","key":"1082_CR231","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/20024091064264","volume":"32","author":"HJ Clewell","year":"2002","unstructured":"Clewell HJ, Teeguarden J, McDonald T, et al. Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Crit Rev Toxicol. 2002;32(5):329\u201389.","journal-title":"Crit Rev Toxicol"},{"issue":"8","key":"1082_CR232","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.biopsych.2007.03.001","volume":"62","author":"KP Cosgrove","year":"2007","unstructured":"Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry. 2007;62(8):847\u201355.","journal-title":"Biol Psychiatry"},{"key":"1082_CR233","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03602532.2023.2297154","volume":"56","author":"M Zhang","year":"2023","unstructured":"Zhang M, Rottsch\u00e4fer V, de Lange ECM. The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure. Drug Metab Rev. 2023;56:1\u201330.","journal-title":"Drug Metab Rev"},{"issue":"Suppl. 3","key":"1082_CR234","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1093\/infdis\/jiu232","volume":"209","author":"M Muenchhoff","year":"2014","unstructured":"Muenchhoff M, Goulder PJ. Sex differences in pediatric infectious diseases. J Infect Dis. 2014;209(Suppl. 3):S120\u20136.","journal-title":"J Infect Dis"},{"issue":"18","key":"1082_CR235","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1097\/QAD.0000000000002012","volume":"32","author":"EE Sundermann","year":"2018","unstructured":"Sundermann EE, Heaton RK, Pasipanodya E, et al. Sex differences in HIV-associated cognitive impairment. AIDS. 2018;32(18):2719\u201326.","journal-title":"AIDS"},{"key":"1082_CR236","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bbi.2020.05.037","volume":"88","author":"C Liguori","year":"2020","unstructured":"Liguori C, Pierantozzi M, Spanetta M, et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun. 2020;88:11\u20136.","journal-title":"Brain Behav Immun"},{"issue":"7","key":"1082_CR237","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41577-020-0348-8","volume":"20","author":"EP Scully","year":"2020","unstructured":"Scully EP, Haverfield J, Ursin RL, et al. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immuno. 2020;20(7):442\u20137.","journal-title":"Nat Rev Immuno"},{"issue":"7","key":"1082_CR238","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1128\/JVI.72.7.5661-5668.1998","volume":"72","author":"KN Fish","year":"1998","unstructured":"Fish KN, Soderberg-Naucler C, Mills LK, et al. Human cytomegalovirus persistently infects aortic endothelial cells. J Virol. 1998;72(7):5661\u20138.","journal-title":"J Virol"},{"issue":"1","key":"1082_CR239","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.virol.2005.09.015","volume":"344","author":"VR Racaniello","year":"2006","unstructured":"Racaniello VR. One hundred years of poliovirus pathogenesis. Virology. 2006;344(1):9\u201316.","journal-title":"Virology"},{"issue":"1","key":"1082_CR240","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/0042-6822(91)90145-2","volume":"183","author":"F Lafay","year":"1991","unstructured":"Lafay F, Coulon P, Astic L, et al. Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation. Virology. 1991;183(1):320\u201330.","journal-title":"Virology"},{"issue":"3","key":"1082_CR241","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1053\/j.gastro.2011.11.028","volume":"142","author":"NF Fletcher","year":"2012","unstructured":"Fletcher NF, Wilson GK, Murray J, et al. Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology. 2012;142(3):634\u201343.","journal-title":"Gastroenterology"},{"issue":"4","key":"1082_CR242","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1128\/CMR.00045-12","volume":"25","author":"TM Colpitts","year":"2012","unstructured":"Colpitts TM, Conway MJ, Montgomery RR, et al. West Nile virus: biology, transmission, and human infection. Clin Microbiol Rev. 2012;25(4):635\u201348.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"1082_CR243","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/v3060811","volume":"3","author":"SM Lim","year":"2011","unstructured":"Lim SM, Koraka P, Osterhaus ADME, et al. West Nile virus: immunity and pathogenesis. Viruses. 2011;3(6):811\u201328.","journal-title":"Viruses"},{"issue":"12","key":"1082_CR244","first-page":"1328","volume":"74","author":"AA Malygin","year":"2009","unstructured":"Malygin AA, Bondarenko EI, Ivanisenko VA, et al. C-terminal fragment of human laminin-binding protein contains a receptor domain for venezuelan equine encephalitis and tick-borne encephalitis viruses. Biochemistry. 2009;74(12):1328\u201336.","journal-title":"Biochemistry"},{"issue":"12","key":"1082_CR245","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/jmr.2399","volume":"27","author":"BN Zaitsev","year":"2014","unstructured":"Zaitsev BN, Benedetti F, Mikhaylov AG, et al. Force-induced globule-coil transition in laminin binding protein and its role for viral-cell membrane fusion. J Mol Recognit. 2014;27(12):727\u201338.","journal-title":"J Mol Recognit"},{"key":"1082_CR246","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.virol.2017.04.012","volume":"507","author":"M Palus","year":"2017","unstructured":"Palus M, Vancova M, Sirmarova J, et al. Tick-borne encephalitis virus infects human brain microvascular endothelial cells without compromising blood-brain barrier integrity. Virology. 2017;507:110\u201322.","journal-title":"Virology"},{"issue":"5700","key":"1082_CR247","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1126\/science.1103492","volume":"306","author":"GF Elphick","year":"2004","unstructured":"Elphick GF, Querbes W, Jordan JA, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science. 2004;306(5700):1380\u20133.","journal-title":"Science"},{"issue":"4","key":"1082_CR248","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jcv.2009.12.006","volume":"47","author":"R Boothpur","year":"2010","unstructured":"Boothpur R, Brennan DC. Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol. 2010;47(4):306\u201312.","journal-title":"J Clin Virol"},{"issue":"1","key":"1082_CR249","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.virol.2007.02.018","volume":"364","author":"ML Chapagain","year":"2007","unstructured":"Chapagain ML, Verma S, Mercier F, et al. Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A. Virology. 2007;364(1):55\u201363.","journal-title":"Virology"},{"issue":"3","key":"1082_CR250","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008371","volume":"16","author":"BA O\u2019Hara","year":"2020","unstructured":"O'Hara BA, Morris-Love J, Gee GV, et al. JC virus infected choroid plexus epithelial cells produce extracellular vesicles that infect glial cells independently of the virus attachment receptor. PLoS Pathog. 2020;16(3):e1008371.","journal-title":"PLoS Pathog"},{"issue":"12","key":"1082_CR251","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000215","volume":"4","author":"A Alexaki","year":"2008","unstructured":"Alexaki A, Wigdahl B. HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination. PLoS Pathog. 2008;4(12):e1000215.","journal-title":"PLoS Pathog"},{"issue":"11","key":"1082_CR252","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1007\/s12031-020-01767-6","volume":"71","author":"NK Jha","year":"2021","unstructured":"Jha NK, Ojha S, Jha SK, et al. Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations. J Mol Neurosci. 2021;71(11):2192\u2013209.","journal-title":"J Mol Neurosci"},{"issue":"5","key":"1082_CR253","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nm1236","volume":"11","author":"X Wang","year":"2005","unstructured":"Wang X, Huang DY, Huong S-M, et al. Integrin alphavbeta3 is a coreceptor for human cytomegalovirus. Nat Med. 2005;11(5):515\u201321.","journal-title":"Nat Med"},{"issue":"50","key":"1082_CR254","doi-asserted-by":"publisher","first-page":"20037","DOI":"10.1073\/pnas.0709704104","volume":"104","author":"D Wang","year":"2007","unstructured":"Wang D, Yu Q-C, Schr\u00f6er J, et al. Human cytomegalovirus uses two distinct pathways to enter retinal pigmented epithelial cells. Proc Natl Acad Sci U S A. 2007;104(50):20037\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1082_CR255","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1128\/JVI.73.1.205-213.1999","volume":"73","author":"AV Albright","year":"1999","unstructured":"Albright AV, Shieh JT, Itoh T, et al. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J Virol. 1999;73(1):205\u201313.","journal-title":"J Virol"},{"issue":"9","key":"1082_CR256","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.4049\/jimmunol.181.9.6170","volume":"181","author":"A L\u00fcnemann","year":"2008","unstructured":"L\u00fcnemann A, L\u00fcnemann JD, Roberts S, et al. Human NK cells kill resting but not activated microglia via NKG2D- and NKp46-mediated recognition. J Immunol. 2008;181(9):6170\u20137.","journal-title":"J Immunol"},{"issue":"2","key":"1082_CR257","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030691","volume":"7","author":"Z Maherally","year":"2012","unstructured":"Maherally Z, Smith JR, An Q, et al. Receptors for hyaluronic acid and poliovirus: a combinatorial role in glioma invasion? PLoS ONE. 2012;7(2):e30691.","journal-title":"PLoS ONE"},{"issue":"2","key":"1082_CR258","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/viro.2000.0418","volume":"273","author":"M Gromeier","year":"2000","unstructured":"Gromeier M, Solecki D, Patel DD, et al. Expression of the human poliovirus receptor\/CD155 gene during development of the central nervous system: implications for the pathogenesis of poliomyelitis. Virology. 2000;273(2):248\u201357.","journal-title":"Virology"},{"issue":"6","key":"1082_CR259","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/j.1471-4159.2008.05723.x","volume":"107","author":"H Xia","year":"2008","unstructured":"Xia H, Lazartigues E. Angiotensin-converting enzyme 2 in the brain: properties and future directions. J Neurochem. 2008;107(6):1482\u201394.","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"1082_CR260","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijpharm.2007.07.004","volume":"348","author":"TF Palmberger","year":"2008","unstructured":"Palmberger TF, Hombach J, Bernkop-Schn\u00fcrch A. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir. Int J Pharm. 2008;348(1\u20132):54\u201360.","journal-title":"Int J Pharm"},{"issue":"3","key":"1082_CR261","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.medmal.2017.01.005","volume":"47","author":"JP Stah","year":"2017","unstructured":"Stahl JP, Azouvi P, Bruneel F, et al. Guidelines on the management of infectious encephalitis in adults. Med Mal Infect. 2017;47(3):179\u201394.","journal-title":"Med Mal Infect"},{"issue":"5","key":"1082_CR262","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/imj.12749","volume":"45","author":"PN Britton","year":"2015","unstructured":"Britton PN, Eastwood K, Paterson B, et al. Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand. Intern Med J. 2015;45(5):563\u201376.","journal-title":"Intern Med J"},{"issue":"1\u20132","key":"1082_CR263","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijpharm.2010.10.017","volume":"403","author":"M Li","year":"2011","unstructured":"Li M, Si L, Pan H, et al. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion. Int J Pharm. 2011;403(1\u20132):37\u201345.","journal-title":"Int J Pharm"},{"issue":"10","key":"1082_CR264","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1211\/0022357991776804","volume":"51","author":"I Tamai","year":"1999","unstructured":"Tamai I, Sai Y, Ono A, et al. Immunohistochemical and functional characterization of pH-dependent intestinal absorption of weak organic acids by the monocarboxylic acid transporter MCT1. J Pharm Pharmacol. 1999;51(10):1113\u201321.","journal-title":"J Pharm Pharmacol"},{"key":"1082_CR265","volume-title":"WHO guidelines approved by the Guidelines Review Committee, in consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. WHO guidelines approved by the Guidelines Review Committee, in consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: World Health Organization; 2021."},{"issue":"2","key":"1082_CR266","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1124\/dmd.112.048918","volume":"41","author":"MJ Reese","year":"2013","unstructured":"Reese MJ, Savina PM, Generaux GT, et al. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor. Drug Metab Dispos. 2013;41(2):353\u201361.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"1082_CR267","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/00498254.2016.1158886","volume":"47","author":"J Reznicek","year":"2017","unstructured":"Reznicek J, Ceckova M, Cerveny L, et al. Emtricitabine is a substrate of MATE1 but not of OCT1, OCT2, P-gp, BCRP or MRP2 transporters. Xenobiotica. 2017;47(1):77\u201385.","journal-title":"Xenobiotica"},{"issue":"12","key":"1082_CR268","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/FPC.0b013e32835879a8","volume":"22","author":"Y Ghodke","year":"2012","unstructured":"Ghodke Y, Anderson PL, Sangkuhl K, et al. PharmGKB summary: zidovudine pathway. Pharmacogenet Genom. 2012;22(12):891\u20134.","journal-title":"Pharmacogenet Genom"},{"issue":"5","key":"1082_CR269","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/cts.12815","volume":"13","author":"K Yang","year":"2020","unstructured":"Yang K. What do we know about remdesivir drug interactions? Clin Transl Sci. 2020;13(5):842\u20134.","journal-title":"Clin Transl Sci"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01082-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-024-01082-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01082-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T17:10:36Z","timestamp":1713460236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-024-01082-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":269,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1082"],"URL":"https:\/\/doi.org\/10.1007\/s40263-024-01082-3","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]},"assertion":[{"value":"10 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Ming Sun, Martijn L. Manson, Tingjie Guo, and Elizabeth C. M. de Lange have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Wrote or contributed to the writing of the manuscript: MS, MLM, TG, and ECMdL.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}